14 results
6-K
EX-99.1
AMYT
Amryt Pharma Plc
25 Feb 22
Current report (foreign)
4:05pm
as to “materiality”, “Material Adverse Effect” or similar language shall be true and correct (after giving effect to any qualification therein) in all respects … shall be true and correct in all material respects (without duplication of materiality qualifiers) on and as of the date of any such Credit Extension
424B3
AMYT
Amryt Pharma Plc
1 Jul 21
Prospectus supplement
5:20pm
to be performed by it at or prior to the effective time;
subject to certain exceptions and materiality standards provided in the merger agreement … time;
subject to certain exceptions and materiality standards provided in the merger agreement, the representations and warranties of Amryt being true
F-4/A
AMYT
Amryt Pharma Plc
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
to certain exceptions and materiality standards provided in the merger agreement, the representations and warranties of Chiasma being true and correct … obligations under the merger agreement required to be performed by it at or prior to the effective time;
subject to certain exceptions and materiality
F-4
boz unb9d
15 Jun 21
Registration of securities (foreign)
12:00am
424B3
w6ovssxgnies
2 Jun 21
Prospectus supplement
10:10am
424B3
y7x02z35149liy6bsq
2 Jun 21
Prospectus supplement
10:09am
6-K
bz3928yr6aa9g87d
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
wub4fpkj ib5r2n
5 May 21
Agreement and Plan of Merger
5:19pm
F-1
EX-10.5
gthh9ss
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.1
1pkmmbi
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-3.1
r0mdo7bj7d4vvd0el cb
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
EX-10.5
bob6d1yfpwrx o1
11 May 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next